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The North Carolina Diabetic Retinopathy Telemedicine Network:  Program Evaluation 
Abstract 
Importance:  Retinal tele-screening with remote expert interpretation is an emerging 
strategy for providing diabetic retinopathy (DR) evaluations in the primary care setting and is 
especially useful in reaching patients living in rural and underserved areas. 
Objective:  To evaluate the effectiveness of telemedicine in providing retinal screenings 
to patients with diabetes who participated in the North Carolina Diabetic Retinopathy 
Telemedicine Network (NCDRTN). 
Design:  Cross-sectional study conducted from January 2014 to November 2015. 
Setting:  5 Area Health Education Center (AHEC) primary care clinics which serve rural 
and underserved populations in North Carolina. 
Participants:  1787 patients with diabetes received retinal screening photographs with 
remote expert interpretation to determine the presence and severity of DR.  Participants included 
patients aged 18 years or older with Type I or Type II diabetes mellitus who presented to these 5 
clinics for their routine diabetes care.  Of these patients, 1661 with complete data were included 
in the statistical analysis. 
Main Outcomes and Measures:  Identification of patient characteristics associated with 
DR and ophthalmologist referral as well as percentage increase in DR screening rates at the 5 
clinics. 
Results:  1661 patients with complete data were included in the analysis.  1323 (79.7%) 
had no DR, 183 (11.0%) had DR without referral, and 155 (9.3%) had DR with referral.  Age 
and race were not associated with DR, but were associated with referral.  Older patients (OR = 
1.28) and African American patients (OR = 1.84) or another minority (OR = 2.19) had greater 
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odds of referral when compared to those who were Caucasian and/or younger by 10 year 
increments.  Patients with higher HgA1c levels (OR = 1.19) and longer duration of diabetes (OR 
= 1.76) had increased odds of having DR that required referral.  Stroke (OR = 1.65) and kidney 
disease (OR = 1.59) were the comorbid conditions most associated with DR and referral in our 
study population.  The mean reported pre-implementation DR screening rate among the 5 clinics 
was 25.6% and the post-implementation DR screening rate in active patients was 40.4%. 
Conclusions and Relevance:  When implemented in the primary care setting, 
telemedicine is an effective intervention for increasing the reach of DR screening in patients with 
diabetes who otherwise face access barriers to proper and timely eye care.   
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Introduction 
Diabetic retinopathy (DR) is the most common microvascular complication of diabetes 1 
and is the leading cause of new cases of blindness among adults aged 20–74 years in the United 
States (U.S.). 2  Recent estimates reveal 4.2 million or 28.5% of people with diabetes over age 40 
have DR and 655,000 of these individuals have vision-threatening retinal disease. 2  By the year 
2050, the prevalence of DR in Type I and Type II diabetic patients aged 40 and older is projected 
to increase to 16.0 million (from 5.5 million in 2005) and the prevalence of vision-threatening 
DR is projected to increase to 3.4 million (from 1.2 million in 2005). 3 
Early detection of DR is crucial to prevent the loss of vision.  Medical and surgical 
therapies have dramatically reduced the progression of DR.  In fact, timely intervention with 
laser therapy and anti-VEGF therapy can reduce the risk of severe vision loss by over 90%. 4–12 
While national and international DR screening guidelines have been established by organizations 
such as the American Academy of Ophthalmology (AAO), National Committee for Quality 
Assurance (NCQA), National Eye Institute (NEI), Centers for Disease Control and Prevention 
(CDC), and the World Health Organization (WHO), screening rates in the U.S. remain low in the 
predominant health care paradigm wherein patients with diabetes are referred from primary care 
providers to ophthalmologists for dilated eye examinations to determine whether DR is present.  
On average, less than 50% of patients with diabetes meet current annual screening 
recommendations. 13–17  Socioeconomic and geographic barriers to care, delayed referrals from 
primary care providers, and lack of patient awareness regarding the importance of annual retinal 
examinations have been cited as reasons for low screening rates. 18–21  Among minorities, 
language, cultural, and educational barriers may also contribute to disparities in screening and 
treatment. 15,17,22  Timely treatment with panretinal and focal laser photocoagulation surgery has 
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been proven in the ETDRS, DRS, and DRVS trials 8–10 to significantly decrease vision loss from 
diabetes.  A recent landmark trial from the Diabetic Retinopathy Clinical Research Network has 
demonstrated that anti-VEGF therapy can preserve visual acuity to a similar degree as laser 
therapy for proliferative DR. 12  Thus, the challenge lies first in the early identification of patients 
at risk of vision loss on a societal scale.   
Telemedicine is an emerging strategy for improving DR evaluation through retinal 
imaging with remote expert interpretation.  Introducing this technology at the point of care of the 
primary physician could substantially reduce many of the above barriers and improve early 
detection of retinopathy.  While other countries such as the United Kingdom and France have 
demonstrated high rates of DR screening through telemedicine programs, 23–25 large-scale data in 
the U.S. is sparse and limited primarily to the Veterans Administration (VA) system.  While the 
VA has achieved a high level of efficiency and quality of DR screening for their patients, 26–29 it 
may be difficult to generalize their findings to practice settings with a diverse patient and payor 
mix. 
In the present study, our goal was to evaluate the effectiveness of telemedicine as an 
intervention for increasing the reach of DR screening for patients with diabetes who have eye 
care access barriers in North Carolina.  By collecting patient metadata in this diverse clinic 
population, we also examined factors associated with DR and ophthalmologist referral.  
 
Methods  
The North Carolina Diabetic Retinopathy Telemedicine Network (NCDRTN) is an 
innovative public health initiative that aims to use retinal tele-screening to reduce rates of vision 
loss from DR by providing efficient, effective retinal evaluation to patients with diabetes who 
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live in some of the most rural and underserved parts of the state.  This program was funded by 
The Duke Endowment and is a collaboration between the University of North Carolina (UNC) 
Chapel Hill Department of Ophthalmology and 5 Area Health Education Center (AHEC) 
affiliated primary care clinics across North Carolina:  Mountain AHEC (MAHEC) in Asheville, 
Moses Cone Hospital Internal Medicine (MCH-IM) and Family Medicine (MCH-FM) clinics in 
Greensboro, East Carolina University (ECU) Department of Family Medicine, and Southern 
Regional AHEC (SRAHEC) in Fayetteville.  The program evaluation associated with this project 
was approved by the UNC Institutional Review Board. 
Patient recruitment.  Patients were included in this study if they had Type I or Type II 
diabetes mellitus, were 18 years of age or older, and received primary care for their diabetes at 
one of the 5 AHEC clinics.  Patients were excluded if they were unable to undergo imaging due 
to cognitive impairment or if they already had a documented retinal exam within the past 12 
months with an eye care provider.  Retinal tele-screening was performed in the primary care 
clinics, which serve large numbers of Medicare and Medicaid recipients, uninsured patients, and 
racial/ethnic minorities.  Staff at each clinic identified and enrolled patients with diabetes who 
had not received a retinal exam within the past 12 months into the NCDRTN.  Patients were 
identified from clinic rosters on the day of service or were contacted ahead of their scheduled 
diabetes care visits for enrollment into the program.  Clinic electronic medical records (EMR) 
were also queried to identify and recruit patients who were due for retinal screening.  In some 
instances, clinics used computer monitor advertisements within clinic waiting areas, 
informational flyers in English and Spanish, and patient education brochures to recruit patients 
into the program.   
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 Retinal photography & image transfer.  Depending on the available resources at each 
clinic, existing nursing staff, clinic technicians, and/or ancillary personnel were trained as retinal 
fundus camera operators.  Patients underwent retinal fundus photography at the most convenient 
time during their visit so that their imaging session could be seamlessly integrated into the 
existing clinic flow.  The MAHEC, SRAHEC, MCH-IM, and MCH-FM clinics each used a 
manual table-top digital nonmydriatic (undilated) fundus camera (VisuCam Pro NM; Carl Zeiss 
Meditec AG, Jena, Germany), whereas the ECU clinic used a fully automated table-top digital 
nonmydriatic fundus camera (Centervue DRS; Centervue, Fremont, CA) to capture a single 45 
macula-centered retinal photograph in both eyes.  In the vast majority of cases, no pupillary 
dilation was required.   
After assessment of image quality, the DICOM (Digital Imaging and Communications in 
Medicine) images and patient metadata were securely transmitted via the RetinaVue Network 
(Welch Allyn, Skaneateles, NY), which is a HIPAA-compliant, web-based protocol for secure 
image transmission. 30  Metadata included standard clinical diabetes metrics as well as social 
determinants of health as defined under “Data Collection” below.  A single retina specialist (SG) 
at the UNC-Chapel Hill Department of Ophthalmology remotely interpreted the retinal images 
for the presence of DR and, if present, classified the DR severity according to the International 
Clinical DR and DME disease severity scales. 31  An electronic report containing the retinal 
images, the stratified level of DR, a preliminary diagnosis for each eye, and a recommended 
management plan based upon DR severity was sent electronically to the originating primary care 
provider within 24 hours for incorporation into the patient’s EMR.  In general, patients with no 
DR or mild non-proliferative DR (NPDR) were scheduled for repeat follow-up photographs in 
12 months within the NCDRTN.  Patients with mild to moderate NPDR were scheduled for 
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repeat follow-up photographs in 6 months.  Patients with diabetic macular edema (DME), severe 
NPDR or proliferative DR (PDR), or ungradable images were scheduled for a referral visit with 
an ophthalmologist in the patient’s local community for additional evaluation and treatment as 
needed. 
Patient education.  Prior to NCDRTN implementation, diabetic patients in the AHEC 
clinics received little to no education regarding DR.  Retinal tele-screening in these clinics 
facilitated the education of patients regarding their diabetes and its effect on their vision.  To 
raise patient and provider awareness of the importance of retinal screening to reduce 
complications of diabetes, each clinic was provided with educational materials from the National 
Eye Institute, including flipcharts, posters, YouTube videos, and brochures in both English and 
Spanish.  Each clinic tailored these materials to their own needs and also developed other 
educational tools for use with their existing diabetes education resources. 
Data collection.  Along with patient demographics such as age, gender, and 
race/ethnicity, camera operators also entered data on standard diabetes outcomes (i.e., 
hemoglobin A1c (HbA1c) and duration of diabetes) and other related conditions (i.e., smoking, 
hypertension, coronary artery disease, history of stroke and/or myocardial infarction, kidney 
disease, and family history of glaucoma).  Data on social determinants of health, such as 
residential ZIP code, education level, employment status, and insurance status were also 
collected.  This information was gathered via patient history, patient questionnaire, and/or by 
abstraction from the patient’s EMR at each clinic site.  All data were securely transmitted to the 
retina specialist at the UNC-Chapel Hill Department of Ophthalmology via the RetinaVue 
Network.  Prior to and after NCDRTN implementation, retinal screening rates were collected 
from each clinic based on the number of patients with diabetes that these clinics serve. 
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Data analysis.  The eyes of 1787 patients were assessed for the presence of DR of 
various stages of severity (none, mild NPDR, moderate NPDR, severe NPDR, PDR) and for the 
presence or absence of DME.  Of these, six patients below the age of 18 years were excluded.  
Demographic and clinical variables included several categorical and continuous variables.  Race, 
gender, education level, insurance status, smoking, hypertension, coronary artery disease, stroke, 
previous myocardial infarction, family history of glaucoma, and kidney disease were categorical 
variables, whereas age, HbA1c, and duration of diabetes were continuous variables.  Importantly, 
a three-category primary outcome variable for DR and referral at the individual level was 
determined from exam results for pairs of eyes taking into account that there were some 
ungradable images.  Patients were considered to have no DR if the diagnosis in both eyes was no 
DR.  If either eye had mild or moderate NPDR without DME, then the individual was placed in 
the DR without referral category; if either eye had severe NPDR, PDR, DME, or an ungradable 
image, the individual was placed in the DR with referral category.   
The goal of the statistical analysis was to identify patient characteristics associated with 
DR and referral.  A complete case analysis was used so that any patients with missing data were 
deleted from the analysis.  Preliminary bivariate analyses were carried out by cross-tabulating 
categorical variables with the primary outcome and calculating means, standard deviations, and 
range for continuous variables with respect to the three groups defined by no DR, DR without 
referral, and DR with referral.  Pearson chi-square tests for the categorical variables were 
computed to test the null hypothesis of no association with the primary outcome.  ANOVA was 
used to assess whether means of the continuous variables varied across the three categories of the 
primary outcome.  Considering the infrequent occurrence of DR, multivariable analysis treated 
insurance status as a dichotomous variable (insured vs. uninsured), education categories of 
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“some college” and “college degree or more” were combined, and Hispanic and Other race were 
combined. 
A multivariable cumulative logits model analysis was used to identify characteristics of 
patients associated with DR or referral.  Two cumulative logits were defined from the three-
category primary outcome. The first logit was the odds of DR (regardless of referral or not) 
relative to the odds of no DR.  The second logit was the odds of referral relative to the odds of no 
referral (no DR or DR without referral).  Initially, a “full” proportional odds model including all 
the covariates was fitted; this consisted of two logistic regressions where all covariates shared the 
same value of the regression coefficient across the two logits.  An omnibus chi-square score test 
for the proportional odds assumption was computed.  If it was not statistically significant at the 
0.05 significance level, stepwise backwards elimination of covariates was conducted to 
determine a final proportional odds model with a criterion of p < 0.05 for a covariate to stay in 
the model.  However, if the score test rejected the null hypothesis of proportional odds for all 
covariates (p < 0.05), the analysis proceeded to two further stages.  First, a stepwise forward 
selection procedure was conducted to identify a best fitting partial proportional odds model 
whereby a subset of covariates was identified to have distinct values of their regression 
coefficients in the two logits.  Each step in this stage involved conducting a Wald chi-square test 
for the proportional odds assumption of a single covariate; when p < 0.05, the model was 
expanded to allow separate regression coefficients for the covariate.  Inclusion of covariates 
having unequal slopes proceeded until all remaining single-covariate proportional odds tests had 
p > 0.05.  The final stage of model selection involved applying stepwise backwards elimination 
for the covariates for which the proportional odds was maintained.  Finally, multivariable 
adjusted odds ratios and their 95% confidence intervals were computed for covariates in the final 
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partial proportional odds model.  PROC LOGISTIC in SAS 9.4 (Cary, NC) was used for fitting 
the cumulative logits models; details of these models are provided in the statistical appendix. 
 
Results 
A total of 1787 patients with diabetes from 5 AHEC primary care clinics were evaluated 
for DR within our ocular telehealth network from January 2014 to November 2015.  Overall, 
2006 retinal photographs were taken as some patients returned for follow-up during the study 
period.  For the purposes of this study, only data from the first visit was used in the analysis. 
Prior to program implementation, the 5 clinics were asked to report the total number of 
patients with diabetes they serve and the associated retinal screening rate for that 
population.  The overall population of patients with diabetes across these 5 sites was reported as 
5905 people, and the mean reported screening rate was 25.6%.  After program implementation, 
to determine the effectiveness of the NCDRTN at reaching “active” patients with diabetes within 
the overall population, the 5 clinics were asked to provide the number of diabetics who had at 
least one point-of-care HbA1c measurement in the past twelve months.  Based on this definition 
of “active”, 4664 people were reported as active patients with diabetes, and the mean reported 
post-implementation screening rate was 40.4%. 
Table 1 provides a detailed summary of patient characteristics for each clinic site.  The 
mean age of patients was 55.4 years.  The overall mean HbA1c was 7.8% and overall mean 
duration of diabetes was 9.2 years.  Women made up a larger percentage of the study population 
when compared to men (62.7% vs. 37.3%).  ECU and MCH-IM screened a larger proportion of 
African American patients (79.3% and 70.4%, respectively), whereas MAHEC screened a 
mostly Caucasian population (75.7%).  Of note, MAHEC also had the lowest percentage of 
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smokers.  MCH-IM had higher proportions of coronary artery disease, stroke, kidney disease, 
and family history of glaucoma than the other sites.  MCH-IM and MCH-FM also had a higher 
percentage of uninsured patients with lower education levels compared to the other sites. 
The statistical analysis was based on 1661 patients with complete data, where 1323 
(79.7%) had no DR, 183 (11.0%) had DR without referral, and 155 (9.3%) had DR with referral.  
Half of 155 patients requiring referral were due to an inadequate image, thus making our 
ungradable image rate 4.6%.  Coronary artery disease, hypertension, stroke, kidney disease, age, 
HbA1c, and diabetes duration were associated with the primary outcome (no DR, DR without 
referral, and DR with referral) and these relationships were statistically significant (Table 2 and 
3).  In the initial multivariable proportional odds model, the omnibus chi-square score test 
rejected the proportional odds assumption (QS, 15 = 34.8; p = 0.004).  In the second stage forward 
selection procedure, covariate-specific Wald tests sequentially rejected assumptions of 
proportional odds for age (QW,1 = 20.1; p < 0.001) and race (QW,2 = 8.36; p = 0.015).  The final 
partial proportional odds model contained age, race, HbA1c, diabetes duration, stroke, and 
kidney disease (Table 4).  Interestingly, age and race were not associated with having DR, 
however, they were associated with the decision for referral.  In particular, for every 10 year 
increase in age, patients had 1.28 times the odds of referral compared to younger patients.  
African Americans had 1.84 times the odds of referral compared to Caucasians, and patients of 
other races had 2.19 times the odds of referral compared to Caucasians.  For every one unit 
increase of HbA1c, patients had 1.19 times the odds of having DR versus having no DR and 
receiving referral versus no referral.  Also, for every additional 10 years of diabetes duration, 
patients had 1.76 times the odds of having DR versus no DR and receiving referral versus no 
referral.  Patients with stroke had 1.65 times the odds of having DR versus no DR and receiving 
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referral versus no referral.  Those with kidney disease had 1.59 times the odds of having DR 
versus no DR and receiving referral versus no referral.   
Table 5 shows that other diagnoses can also be incidentally diagnosed using retinal tele-
screening.  In our study, a total of 50 patients had another diagnosis besides DR, including age-
related macular degeneration, drusen, glaucoma, or some other ophthalmic condition.  Of those 
who were referred to an ophthalmologist for follow-up care, 60.4% completed the referral visit. 
 
Discussion 
Through the implementation of a retinal tele-screening program for DR evaluation in 
primary care clinics that spanned the state of North Carolina, we have demonstrated that point-
of-care retinal screening coupled with remote expert interpretation reduced access barriers and 
improved DR screening rates in a diverse group of relatively underserved patients with Type I 
and II diabetes.  As expected, our findings showed that higher HbA1c levels and longer diabetes 
duration were associated with advanced DR that required referral.  Stroke and kidney disease 
were the comorbid conditions that were most significantly associated with DR and referral in our 
study population.  In terms of social determinants of health, our findings are similar to those of 
recent studies that have demonstrated the effectiveness of telemedicine in reaching underserved 
populations in both remote and rural areas as well as urban settings across the United States. 19–
21,32–35  Specifically, racial and ethnic minorities constituted 64.5% of our network population, 
women outnumbered men (62.7% vs. 37.3%), and 72.8% of all patients were publicly insured or 
uninsured.  The statewide prevalence of diabetes in minorities in North Carolina is estimated at 
41.6%, 36 which suggests that our telemedicine intervention increased access to retinal 
evaluations in these traditionally underserved groups.  Although race itself was not associated 
 Jani 16 of 75 
 
with having DR, the decision for referral was associated with being a minority, meaning that not 
only were a large proportion of these patients accessing our services, but they were also 
receiving necessary referrals to further ophthalmic care when needed.  It has been shown that 
racial and ethnic differences are associated with low diabetic eye examination rates despite 
insurance status, 17 which lends further reason to explore the potential of telemedicine in 
reducing access barriers for these populations. 
DR is a critically important public health problem because visual impairment from this 
disease is detrimental to patients’ personal independence, economic productivity and 
employment, and overall quality of life.  Demographic trends also suggest a disproportionate 
increase in DR in minority and elderly populations. 2,3,37  As the prevalence of diabetes mellitus 
is projected to increase from 25 million Americans to a staggering 125 million Americans by the 
year 2050, 38 the number of patients with diabetes requiring annual retinal screening may far 
exceed the capacity of the eye care providers who currently see less than half of the diabetic 
patients needing evaluation for DR.   
The implementation of ocular telemedicine programs provides an opportunity to build on 
the relationship of primary care physicians and their patients in several ways.  First, telemedicine 
presents an opportunity to shift the paradigm of diabetic eye care to one in which primary care 
providers can play a more instrumental role in the prevention, screening, and monitoring of this 
eye disease.  Second, not only does the ocular telemedicine approach increase detection and 
surveillance rates of individuals with DR, but it also helps identify those individuals who can be 
managed and monitored by their primary care providers using a retinal camera in the primary 
care clinic.  In our cohort, 80% of patients with diabetes had no DR and needed only annual 
photographs for surveillance and 20% had some degree of DR.  Telemedicine facilitated referrals 
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to the ophthalmologist for only those patients at risk of vision loss and requiring treatment or 
those who had ungradable images.  
Potential economic benefits at every level should not be overlooked.  By requiring fewer 
subspecialist visits through more targeted referrals to ophthalmologists, both the patient and 
healthcare system incur fewer costs.  Primary care clinics benefit economically, since clinics 
which meet performance measures such as NCQA and Healthcare Effectiveness Data and 
Information Set (HEDIS) for diabetic care are reimbursed at a higher rate by insurers. 39  
Additionally, the technical component of obtaining retinal photographs – which is separately 
billable from the image interpretation fee in many states – can help to offset the administrative 
costs for the primary care physician.  By identifying patients at risk of vision loss early in the 
course of disease, ocular telemedicine programs have the potential to decrease costs to the health 
care system and society by reducing the economic and social burden of low vision and blindness. 
Major strengths of our study are that we included a relatively complete set of patient data 
from 5 different primary care clinics across a geographically diverse state and we also evaluated 
a number of clinical and socioeconomic determinants of health.  Having a single reader assess all 
retinal images provided consistency in diagnosis.  Also, the usefulness of telemedicine as a 
modality for long-term monitoring in preventive diabetic eye care is seen from our relatively low 
referral rate (9.3%) because we monitored those with moderate NPDR or lesser degrees of 
retinopathy within our network. 
The findings of this study should be interpreted in the context of the following 
limitations.  Regarding data collection, a wide variation in pre- and post-implementation 
screening rates highlights the challenge of incorporating retinal screenings in the primary care 
setting.  For example, effective utilization of EMR systems was a challenge throughout the 
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course of our study as each clinic was using a unique EMR system to capture, measure, and track 
data.  Furthermore, a few sites implemented completely new EMR systems during the study 
period and each site underwent at least one EMR update.  Data reporting on screening rates and 
the number of patients with diabetes served by each clinic varied due to constraints on the ability 
to query the different EMR systems among the clinics.  It is therefore likely that the reported 
screening rates underreport the number of patients with diabetes that actually meet ADA 
guidelines for DR screening and treatment in the NCDRTN.  Additionally, examining factors 
associated with DR does not necessarily identify predictors, and increasing DR screening rates 
does not necessarily improve rates of treatment.  However, the identification of patients with 
retinopathy is a critical first step.  Finally, some clinics already have high rates of DR screening 
and the implementation of a telemedicine network would not significantly influence their 
detection rates.  However, patient satisfaction is likely to improve due to the convenience of 
point-of-care screening. 40  
There are several avenues for future work in the arena of retinal tele-screening.  As 
demonstrated by multiple international studies, 41–44 future directions for research could include 
an assessment of patient and provider satisfaction with the convenience of tele-retinal screening 
programs in primary care settings in the U.S.  Also, there has recently been growing interest in 
the development of low-cost and portable retinal imaging equipment which has spurred a great 
deal of innovation in the field of ophthalmic imaging.  For example, the use of hand-held and 
smartphone-enabled cameras holds great promise for delivering on the goal of reaching patients 
in remote and underserved areas, and these intervention methods warrant formal study to 
establish the efficacy and effectiveness of such imaging techniques. 45 
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DR screening via telemedicine in the primary-care setting represents an opportunity for 
primary care physicians to take a more active role in the prevention of a blinding disease, to 
better educate patients with diabetes about the importance of retinal examinations, to facilitate 
appropriate referrals from the primary care provider to the ophthalmologist, and to reinforce and 
streamline follow-up care with ophthalmologists.  Telemedicine screening for DR is a public 
health imperative with the potential to increase surveillance rates, reduce socioeconomic 
disparities, increase access to care, and ultimately prevent vision-threatening DR and improve 
visual outcomes and quality of life for patients with diabetes. 
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Table 1.  Patient Characteristics (No. (%)) by NCDRTN Site (N = 1661) 
 
Characteristic ECU 
(N = 435) 
MAHEC 
(N = 313) 
MCH-FM 
(N = 327) 
MCH-IM 
(N = 270) 
SRAHEC 
(N = 316) 
Total 
(N = 1661) 
Age, mean (SD), y 54.1 (12.2) 58.7 (13.1) 54.4 (12.1) 55.9 (11.0) 54.1 (14.2) 55.4 (12.7) 
Gender       
Female 277 (63.7) 187 (59.7) 214 (65.4) 170 (63.0) 193 (61.1) 1041 (62.7) 
Male 158 (36.3) 126 (40.3) 113 (34.6) 100 (37.0) 123 (38.9) 620 (37.3) 
Race / Ethnicity       
African American 345 (79.3) 53 (16.9) 192 (58.7) 190 (70.4) 141 (44.6) 921 (55.4) 
Caucasian 77 (17.7) 237 (75.7) 85 (26.0) 52 (19.3) 138 (43.7) 589 (35.4) 
Hispanic 8 (1.8) 18 (5.8) 34 (10.4) 16 (5.9) 20 (6.3) 96 (5.8) 
Other 5 (1.2) 5 (1.6) 16 (4.9) 12 (4.4) 17 (5.4) 55 (3.3) 
Diabetes Duration, mean (SD), y 9.3 (8.5) 8.3 (7.9) 8.2 (7.2) 10.3 (8.3) 9.7 (8.8) 9.2 (8.2) 
HbA1c, mean (SD), % 7.9 (2.5) 7.2 (1.9) 7.9 (2.5) 8.0 (2.5) 7.9 (2.4) 7.8 (2.4) 
Smoking       
Yes 119 (27.4) 46 (14.7) 126 (38.5) 76 (28.2) 67 (21.2) 434 (26.1) 
No 316 (72.6) 267 (85.3) 201 (61.5) 194 (71.9) 249 (78.8) 1227 (73.9) 
Insurance       
Medicare 176 (40.5) 157 (50.2) 87 (26.6) 97 (35.9) 118 (37.3) 635 (38.2) 
Medicaid 115 (26.4) 41 (13.1) 44 (13.5) 34 (12.6) 59 (18.7) 293 (17.6) 
Private 120 (27.6) 103 (32.9) 47 (14.4) 45 (16.7) 136 (43.0) 451 (27.1) 
Uninsured 24 (5.5) 12 (3.8) 149 (45.6) 94 (34.8) 3 (1.0) 282 (17.0) 
Education       
Less than High School 87 (20.0) 43 (13.7) 115 (35.2) 97 (35.9) 60 (19.0) 402 (24.2) 
High School degree 222 (51.0) 217 (69.3) 119 (36.4) 107 (39.6) 130 (41.1) 795 (47.9) 
Some College 85 (19.5) 27 (8.6) 66 (20.2) 55 (20.4) 79 (25.0) 312 (18.8) 
College degree or more 41 (9.4) 26 (8.3) 27 (8.3) 11 (4.1) 47 (14.9) 152 (9.2) 
Coronary artery disease       
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Yes 59 (13.6) 30 (9.6) 28 (8.6) 69 (25.6) 44 (13.9) 230 (13.8) 
No 376 (86.4) 283 (90.4) 299 (91.4) 201 (74.4) 272 (86.1) 1431 (86.1) 
Hypertension       
Yes 357 (82.1) 198 (63.3) 229 (70.0) 224 (83.0) 236 (74.7) 1244 (74.9) 
No 78 (17.9) 115 (36.7) 98 (30.0) 46 (17.0) 80 (25.3) 417 (25.1) 
Stroke       
Yes 42 (9.7) 15 (4.8) 15 (4.6) 36 (13.3) 30 (9.5) 138 (8.3) 
No 393 (90.3) 298 (95.2) 312 (95.4) 234 (86.7) 286 (90.5) 1523 (91.7) 
Previous MI       
Yes 44 (10.1) 27 (8.6) 19 (5.8) 34 (12.6) 35 (11.1) 159 (9.6) 
No 391 (89.9) 286 (91.4) 308 (94.2) 236 (87.4) 281 (88.9) 1502 (90.4) 
Kidney Disease       
Yes 53 (12.2) 31 (9.9) 14 (4.3) 47 (17.4) 23 (7.3) 168 (10.1) 
No 382 (87.8) 282 (90.1) 313 (95.7) 223 (82.6) 293 (92.7) 1493 (89.9) 
Family Hx of Glaucoma       
Yes 15 (3.5) 4 (1.3) 7 (2.1) 23 (8.5) 12 (3.8) 61 (3.7) 
No 420 (96.6) 309 (98.7) 320 (97.9) 247 (91.5) 304 (96.2) 1600 (96.3) 
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Table 2.  Characteristics of Individuals:  Frequencies (%) of Categorical Variables (N = 1661) 
 
Characteristic No DR 
(N = 1323, 79.7%) 
DR without Referral 
(N = 183, 11.0%) 
DR with Referral 
(N = 155, 9.3%) 
p value* 
Gender    0.96 
Female 831 (79.8) 113 (10.9) 97 (9.3)  
Male 492 (79.4) 70 (11.3) 58 (9.4)  
Race / Ethnicity    0.070 
African American 713 (77.4) 107 (11.6) 101 (11.0)  
Caucasian 486 (82.5) 64 (10.9) 39 (6.6)  
Hispanic 76 (79.2) 9 (9.4) 11 (11.5)  
Other 48 (87.3) 3 (5.5) 4 (7.3)  
Smoking    0.34 
Yes 338 (77.9) 56 (12.9) 40 (9.2)  
No 985 (80.3) 127 (10.4) 115 (9.4)  
Insurance    0.19 
Medicare 512 (80.6) 59 (9.3) 64 (10.1)  
Medicaid 229 (78.2) 39 (13.3) 25 (8.5)  
Private 368 (81.6) 44 (9.8) 39 (8.7)  
Uninsured 214 (75.9) 41 (14.5) 27 (9.6)  
Education    0.14 
Less than High School 309 (76.9) 53 (13.2) 40 (10.0)  
High School degree 637 (80.1) 76 (9.6) 82 (10.3)  
Some College 253 (81.1) 40 (12.8) 19 (6.1)  
College degree or more 124 (81.6) 14 (9.2) 14 (9.2)  
Coronary artery disease    0.009 
Yes 166 (72.2) 33 (14.4) 31 (13.5)  
No 1157 (80.9) 150 (10.5) 124 (8.7)  
Hypertension    0.041 
Yes 981 (78.9) 134 (10.8) 129 (10.4)  
No 342 (82.0) 49 (11.8) 26 (6.2)  
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Stroke    0.008 
Yes 97 (70.3) 19 (13.8) 22 (15.9)  
No 1226 (80.5) 164 (10.8) 133 (8.7)  
Previous MI    0.11 
Yes 117 (73.6) 21 (13.2) 21 (13.2)  
No 1206 (80.3) 162 (10.8) 134 (8.9)  
Kidney Disease    0.005 
Yes 118 (70.2) 25 (14.9) 25 (14.9)  
No 1205 (80.7) 158 (10.6) 130 (8.7)  
Family Hx of Glaucoma    0.053 
Yes 45 (73.8) 5 (8.2) 11 (18.0)  
No 1278 (79.9) 178 (11.1) 144 (9.0)  
*Pearson chi-squared test; **816 patients had missing employment 
 
Table 3.  Characteristics of Continuous Variables by Main Categories (N = 1661) 
Variable No DR (N = 1323) DR without Referral (N = 183) DR with Referral (N = 155) ANOVA 
 Mean 
(s.d.) 
Min-Max Mean (s.d.) Min-Max Mean (s.d.) Min-Max p-value 
Age 55.3 (12.7) 18.7-93.9 53.3 (12.1) 21.2-85.2 58.0 (12.6) 27.4 – 87.2 
.003 
HbA1c 7.5 (2.3) 4.0 – 17.0 8.7 (2.5) 4.0-14.0 8.6 (2.6) 5.0 – 16.0 
<.001 
Diabetes  
Duration 
8.2 (7.7) 0-54.0 12.8 (9.0) 0–51.0 13.2 (9.2) 0-43.0 
<.001 
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Table 4.  Odds Ratios (95% Confidence Intervals) from Partial Proportional Odds Model 
Variable Odds ratio of 
DR versus no DR 
Odds ratio of 
referral versus no referral 
Age (10 year units) 0.99 (0.90, 1.10) 1.28 (1.11, 1.48) 
African American (vs. Caucasian)  1.21 (0.92, 1.59) 1.84 (1.24, 2.73) 
Other (vs. Caucasian) 1.22 (0.75, 1.98) 2.19 (1.16, 4.11) 
HbA1c* 1.19 (1.13,1.25) 1.19 (1.13,1.25) 
Diabetes Duration* (10 year units) 1.76 (1.53, 2.02) 1.76 (1.53, 2.02) 
Stroke* 1.65 (1.10, 2.48) 1.65 (1.10, 2.48) 
Kidney Disease* 1.59 (1.10, 2.31) 1.59 (1.10, 2.31) 
*Common odds ratio estimate and 95% CI under the proportional odds assumption  
 
Table 5.  Frequencies of Other Diagnoses (N = 50) 
Diagnosis One eye only Both eyes Total Patients 
AMD Grade 1; Dry 0 4 4 
AMD Grade 2; Drusen; Degenerative 0 6 6 
AMD Grade 3; Degeneration; Retinal; Secondary Pigmentary 1 3 4 
AMD Grade 4; Chorioretinal scar; Posterior Pole 0 1 1 
Drusen; Hereditary (extramacular drusen) 3 4 7 
Glaucoma: Optic nerve cupping 4 11 15 
Other diagnosis 8 4 12 
Total 17 33 50 
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GIS-Mapping of Diabetic Retinopathy in North Carolina 
Abstract 
Importance:  Minimal information exists on the use of geographic information systems 
(GIS) mapping for visualizing access barriers to eye care for patients with diabetes. 
Objective:  To use GIS-mapping techniques to visualize the locations and travel times of 
patients participating in the North Carolina Diabetic Retinopathy Telemedicine Network 
(NCDRTN) relative to 5 primary care clinics and to ophthalmologists and primary care providers 
across the state. 
Design:  Cross-sectional study conducted from January 2014 to November 2015. 
Setting:  5 Area Health Education Center (AHEC) primary care clinics which serve rural 
and underserved populations in North Carolina. 
Participants:  1787 patients with diabetes received retinal screening photographs with 
remote expert interpretation to determine the presence and severity of diabetic retinopathy (DR).  
Participants included patients aged 18 years or older with Type I or Type II diabetes mellitus 
who presented to these 5 clinics for their routine diabetes care. 
Main Outcomes and Measures:  Development of qualitative maps illustrating the 
density of patients with diabetes and their distribution around the 5 NCDRTN sites by ZIP code 
and the density of ophthalmologists and primary care providers by ZIP code relative to United 
States (U.S.) Census Urban Areas.  A travel time map was also created using road network 
analysis to determine all areas that can be reached by car in a user-specified amount of time. 
Results:  Whereas the clinics located in Greensboro, Asheville, and Fayetteville screened 
patients from more immediate surrounding areas, the Greenville site had the widest distribution 
of ZIP codes, suggesting that patients travel from greater distances to reach this facility.  Primary 
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care providers were spread somewhat uniformly across the state, whereas ophthalmologists were 
concentrated around urban centers.  Also, the number and type of surface roads surrounding the 
clinics determined the distance and time patients must travel to receive care. 
Conclusions and Relevance:  GIS-mapping is a useful technique for visualizing 
geographic access barriers to eye care for patients with diabetes and may help to identify 
underserved areas that would benefit from the expansion of retinal screening programs via 
telemedicine. 
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Introduction 
Diabetic retinopathy (DR) – a condition in which high blood glucose levels damage the 
blood vessels of the retina – is the most common microvascular complication of diabetes 1 and is 
the leading cause of new cases of blindness among working-age Americans. 2  Recent estimates 
reveal 4.2 million or 28.5% of people with diabetes over age 40 have DR and 655,000 of these 
individuals have vision-threatening retinal disease. 2  By the year 2050, the prevalence of DR in 
Type I and Type II diabetic patients aged 40 and older is projected to increase to 16.0 million 
(from 5.5 million in 2005) and the prevalence of vision-threatening DR is projected to increase to 
3.4 million (from 1.2 million in 2005). 3 
North Carolina has been identified as one of the nation's top ten “diabetes hot spots,” 
where the burden of diabetes will be greatest in the next 10 years.  By 2025, the number of 
people with diabetes in North Carolina is projected to increase to almost 1.9 million at a cost to 
the state of $17.9 billion. 4  In 2012, the prevalence of diabetes among North Carolinians was 
10.4%, 5 which was higher than the national average of 9.3%. 6  Of these patients with diabetes, 
about 20% are already diagnosed with DR, and the other 80% are at risk for developing DR. 7 
Given that patients with early stages of DR are often asymptomatic at the time that 
vision-saving laser treatment should be given, early detection and timely referral to an 
ophthalmologist are imperative to preventing vision loss.  However, in our current eye care 
paradigm, less than 50% 8–11 of patients with diabetes meet the current screening guidelines 12–14 
that recommend annual retinal exams by an ophthalmologist.  Health care access barriers 
resulting from socioeconomic, geographic, transportation, education, language, and cultural 
challenges compromise the quality and effectiveness of DR treatment, thus placing patients with 
diabetes at unnecessary risk for this blinding disease. 
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The North Carolina Diabetic Retinopathy Telemedicine Network (NCDRTN) is an 
innovative screening program that was developed to address the growing burden of DR in the 
state.  This program aims to reduce eye care access barriers and improve DR evaluation by using 
the emerging strategy of telemedicine to bring retinal exams to the point-of-care of the primary 
physician.  The screening network allows primary physicians to remotely capture, send, and 
receive retinal images between the University of North Carolina (UNC) Chapel Hill Department 
of Ophthalmology and 5 Area Health Education Center (AHEC) affiliated primary care clinics 
across North Carolina:  Mountain AHEC (MAHEC) in Asheville, Moses Cone Hospital Internal 
Medicine (MCH-IM) and Family Medicine (MCH-FM) clinics in Greensboro, East Carolina 
University (ECU) Department of Family Medicine in Greenville, and Southern Regional AHEC 
(SRAHEC) in Fayetteville.  From January 2014 to November 2015, our program has provided 
2006 eye screenings to a total of 1787 patients with diabetes across North Carolina.  The results 
of the larger NCDRTN program evaluation are reported separately. 
Recent studies have demonstrated the effectiveness of telemedicine in reaching 
underserved populations in both remote and rural areas as well as urban settings across the 
United States. 15–21  Although geographic and transportation challenges have been cited as 
reasons for which patients with diabetes face access barriers to eye care, visual data analyses of 
such barriers is scant.  The purpose of the present study is to use geographic information systems 
(GIS) mapping techniques to visualize the location of patients participating in the NCDRTN 
relative to our program sites and to ophthalmologists and primary care providers across the state.  
Understanding and visualizing patient and physician location data may allow for better 
identification of areas of need, where access barriers may be preventing patients with diabetes 
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from receiving proper eye care.  Such mapping may also help to inform the future expansion of 
the retinal tele-screening program to other underserved parts of North Carolina. 
 
Methods 
Data collection.  Patient ZIP code data were collected along with medical and 
socioeconomic data at the time of retinal imaging in the primary care provider’s office.  This 
information was collected via patient history, patient questionnaire, and/or by abstraction from 
patients’ medical records.  A total of 1787 patients with either Type I or Type II diabetes mellitus 
were included in the dataset, with 361 (20.2%) having any level of DR and 1426 (79.8%) having 
no DR in either eye.  For the purposes of this study, only patients with DR were mapped since 
they may require further ophthalmologic care or more frequent follow-up within the NCDRTN.  
 Medical practice ZIP code data for licensed, active ophthalmologists and primary care 
providers were obtained directly from the North Carolina Medical Board (Raleigh, NC).  Of a 
total of 36,189 active physicians registered with the North Carolina Medical Board, 571 
ophthalmologists and 7182 primary care providers were included in this study as of December 
2015.  For purposes of this analysis, primary care providers were defined as physicians with an 
active North Carolina medical license who self-classified as practicing in the following primary 
areas:  Internal medicine, family medicine, endocrinology, geriatric medicine, adolescent 
medicine, pediatrics, pediatric endocrinology, general practice, general preventive medicine, and 
public health & general.  Similarly, ophthalmologists were defined as physicians with an active 
North Carolina medical license who self-classified their primary area of practice within 
ophthalmology.  
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Data aggregation.  All maps were generated in ArcGIS software (ArcGIS 10.2.1; Esri).  
To protect the privacy of patients, precise locations were obscured and discrete points for 
patients and physicians (i.e., ophthalmologists and primary care providers) were aggregated to a 
coarser unit of geography via the use of associated ZIP code data.  This methodology also 
allowed for easier interpretation of the maps, especially in the case of visualizing physician 
locations. 
Patients and physicians were separately aggregated to their corresponding ZIP codes to 
derive a count of the number of patients and physicians per ZIP code, respectively.  To facilitate 
a wider variety of visualization options, both patients and physicians were aggregated to 
centroids of ZIP codes. 
To aggregate patients and physicians to ZIP codes, tabular patient and physician datasets 
were summarized to derive a count of the number of occurrences of each 5-digit ZIP code where 
a patient lives or a physician works.  Frequencies of the 5-digit ZIP codes for each table were 
calculated using Pivot Tables in Excel.  Patients who had some level of DR diagnosed in either 
eye were used to calculate ZIP code frequency since these patients would require the most 
stringent follow-up or referral to an ophthalmologist.  The inverse of this selection was also 
made (i.e. patients with no DR diagnosis), and ZIP code frequency was calculated.  For 
physicians, ZIP code frequencies were calculated after selection of the relevant specialties listed 
above. 
Creation of density maps.  Frequency tables were then joined to ZIP code Shapefiles, a 
common format for spatial data within GIS, to allow for displaying the density of patients or 
physicians at the ZIP code level.  To join the data, tabular joins were done in ArcMap:  The 
patient ZIP code frequency tables were joined to a Shapefile of ZIP code polygons and a 
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Shapefile of ZIP code points, using the ZIP code field as a common ID.  This same process was 
carried out for primary care providers and ophthalmologists. 
Once joined, new files for the joins listed above were created, resulting in ZIP code point 
and polygon files that show the number of patients and the number of physicians within each ZIP 
code.  These count data were then used to display the ZIP codes in three different density maps: 
1. A graduated color (choropleth) map showing the number of patients per ZIP code, where 
light colors indicate low values and dark colors indicate high values. 
2. Two dot density maps showing a stylized distribution of physicians within each ZIP code 
polygon.  In these maps, points were randomly scattered within the boundaries of each 
ZIP code polygon, with each point corresponding to a user-defined number of 
individuals.  Given the large number of primary care providers in the dataset, a 1-to-3 dot 
density was selected (compared to a 1-to-1 density for ophthalmologists) in order to 
render the maps more readable.  
Creation of travel time map.  The travel time map was created in ArcMap using tools in the 
Network Analysis toolbox.  “Service areas” – or polygons representing all of the areas that can 
be reached by car in a user-specified amount of time by traversing the real-world road network – 
were created around each of the 5 NCDRTN primary care clinics.  Three different service areas 
were created: 20 minutes, 40 minutes, and 60 minutes. 
 
Results 
 The 5 primary care clinics included in the NCDRTN were chosen to participate in our 
telemedicine study because of the primarily rural and underserved patient populations they serve. 
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Figure 1 illustrates the density of patients with diabetes and their distribution around the 5 
NCDRTN sites by ZIP code.  The Greenville clinic site had the widest distribution of darkly-
shaded ZIP codes, suggesting that more patients are traveling from outlying areas in the eastern 
part of the state to seek medical care at this facility.  The Greensboro, Asheville, and Fayetteville 
sites had a more concentrated distribution of ZIP codes, with most patients deriving from areas 
closer to the clinic sites and a comparatively smaller number of patients traveling from further 
away. 
Figures 2 and 3 demonstrate the density of licensed primary care providers and 
ophthalmologists throughout the state, respectively.  The density of these physicians has been 
plotted by ZIP code relative to U.S. Census Urban Areas that contain ≥ 50,000 people.  Given 
that each black dot in Figure 2 represents 3 primary care providers, this map demonstrates that 
these primary care doctors make up a fifth of all physicians in the state (7182 primary care 
providers of 36,189 total physicians).  These doctors also have a denser coverage of both rural 
and urban parts of the state when compared to ophthalmologists, who are mostly concentrated in 
the urban centers. 
The travel time map allows for visualization of potential access barriers that patients may 
face as a result of the number and type of surface roads available in their geographic area.  As 
shown in Figure 4, the 20 minute service area represents all areas that can be reached within 20 
minutes of travel time.  The 40 minute service area represents all areas that can be reached within 
40 minutes of travel time; this area is displayed as a ring around the 20 minute area, thus 
representing the areas that can be reached in 20-40 minutes of driving.  Likewise, the 60 minute 
service area represents all areas that can be reached within 60 minutes of travel time; this area is 
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displayed as a ring around the 40 minute area, thus representing the areas that can be reached in 
40-60 minutes of driving. 
The city of Greensboro has an extensive network of interstate roads passing through or 
around the city, which better connects patients with the more developed and resource-rich 
metropolitan areas of the North Carolina Piedmont region.  The metropolitan areas of the Triad 
(Greensboro, Winston-Salem, and High Point) and the Triangle (Chapel Hill, Durham, and 
Raleigh) contain a number of well-known health care facilities and hospital centers that offer 
patients in the Greensboro area with ample opportunities for seeking quality care.  In contrast, 
Greenville and Fayetteville are smaller cities with larger surrounding rural areas.  They contain a 
sparser network of small roads with lower travel speeds, which limit patient access to the few 
health care facilities in these two regions.  Those living in the greater Asheville area face an 
additional and unique access barrier since they must contend with mountainous terrain in order to 
travel to the urban portions of Asheville.  Since patients here must use small mountain roads with 
low travel speeds to access health care facilities within the city of Asheville, their perceived 
distance to health clinics may be inflated when compared to those patients who can easily access 
interstate roads for quicker travel.  As such, this travel time barrier may influence the frequency 
and likelihood with which patients living in rural mountain areas seek health care.  Figure 4 thus 
illustrates how travel time along road networks may influence uptake of health care services.  
This map shows that the spread of travel activity is influenced by how easily people can travel 
along interstate corridors, which effectively extend the distance that a person is able to travel in a 
given amount of time.  For example, although patients living in mountainous regions of western 
North Carolina may be close to the MAHEC NCDRTN site based on mileage, their effective 
travel time is considerably lengthened by the circuitous nature of mountain roads in this area.  
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However, patients traveling along I-40 through the Asheville city center would be able to travel 
much further in the same amount of time. 
 
Discussion 
In the first study of its kind, we have demonstrated that GIS-mapping is a useful 
technique for visualizing geographic access barriers to eye care for patients with diabetes.  By 
mapping the statewide distribution of providers serving the primary care needs of diabetic 
patients alongside ophthalmologists in North Carolina relative to the ZIP codes from which 
patients travel to reach our 5 NCDRTN sites, we have shown that patient accessibility to these 
doctors is influenced by the geography and road networks that connect them.  This knowledge 
will help inform the future expansion of the NCDRTN program as we are able to identify 
opportunities for strategic collaborations between primary care providers and ophthalmologists 
across the state.  
To date, there has been minimal published literature on the use of GIS-mapping for 
evaluating geographic access barriers such as distance and travel-time to health care facilities in 
the United States.  A few studies have used spatial analysis to determine how distance to 
hospitals and specialist care affects timely health care delivery, 22–26 and at least two studies have 
used spatial analysis to identify areas of high diabetes prevalence so that public health programs 
can be targeted to places where patient uptake of preventive care services is more likely. 27,28  All 
of these studies demonstrate that GIS-mapping is a useful tool for studying how geographic 
access barriers influence health service delivery and resource allocation. 
As the prevalence of diabetes is projected to increase from 25 million Americans to a 
staggering 125 million Americans by the year 2050, 29 the number of patients with diabetes 
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requiring annual retinal screening will far exceed the capacity of the eye care providers who 
currently see less than half of the diabetic patients needing evaluation for DR.  Coupled with an 
aging population, various access barriers to care, and growing shortages in primary care 
physicians nationwide, 30 the current paradigm for diabetic eye care will not be able to meet 
patients’ needs without employing innovative strategies for health care delivery.  Our study 
shows that telemedicine holds great potential for reducing travel-times and geographic barriers to 
care by allowing physicians to connect over large distances with patients in some of the most 
rural and underserved areas.  However, large-scale and cost-effective implementation of 
sustainable telemedicine systems will require the strategic allocation of health care resources.  
GIS-mapping is a helpful tool for informing the scale-up of such systems as areas can easily be 
identified where investments in telemedicine programs would be most worthwhile.  By using 
publicly available census data, other demographic variables, and socioeconomic determinants of 
health in conjunction with patient medical records, this type of data visualization can help inform 
strategic planning for the expansion of broader public health care services.  Predictive modeling 
can also help to identify catchment areas where disease burden is likely to worsen over time and 
where the need for expanded health care services will be greatest. 
A major strength of our study is that it includes patient data from an innovative eye 
screening program that spans 5 different primary care clinics across a geographically diverse 
state.  These clinics provide health care to patients in both rural and urban areas across the 
mountains, piedmont, and coastal regions of North Carolina.  Given the variety of geographic 
areas included in this study, the number and quality of road networks in these areas also play an 
important role in the access barriers that patients face to receiving quality health care. 
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Although our study included a total of 1787 patients with diabetes, only 361 (20.2%) had 
any level of DR.  Given the small sample size of patients with disease, we were not able to 
visualize whether those facing more geographic barriers to health care also experience higher 
rates of DR.  Additionally, we used coarse, 5-digit ZIP code level data to map to ZIP code 
centroids in order to protect patient privacy.  However, more detailed 9-digit ZIP code level data 
and individual address information may have provided a more accurate visualization of the exact 
distance that patients are travelling to reach our primary care clinic sites. 
Future research should involve larger sample sizes of patients with diabetes to study the 
strength of the correlation between the quality of road networks, geography, and access barriers 
to health care as well as to study how standard clinical diabetes metrics and other socioeconomic 
determinants of health correlate with effective health care delivery. 
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Figure 1. Diabetic Patients in NCDRTN per ZIP Code 
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Figure 2. Density of Primary Care Providers in North Carolina
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Figure 3. Density of Ophthalmologists in North Carolina
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Figure 4. Driving Time to NCDRTN Sites
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APPENDIX A:  Systematic Literature Review 
Abstract 
Purpose:  This review is a synthesis of published articles examining the effectiveness of 
telemedicine in reducing access barriers to diabetic retinopathy (DR) screening in primary care 
settings.  
Methods:  A systematic review of relevant qualitative and quantitative studies was 
conducted.  PubMed, Web of Science, and EMBASE databases were searched using relevant 
keywords and MeSH terms for English language articles published from January 2006 – January 
2016.  Articles were selected and analyzed based on the following criteria:  Study design, 
technology and imaging techniques utilized, setting (location, population), diabetic patient 
demographics and proportion screened, DR classification, and proportion of patients requiring 
referral to an eye care provider.  International studies and technical papers were excluded.  Data 
were abstracted by a single author (PDJ).   
Results:  Six studies met the search criteria.  Only one study was a randomized 
controlled trial demonstrating that telemedicine is highly effective for DR screening when 
compared to traditional surveillance.  All six studies showed that telemedicine increases retinal 
screening rates in the primary care setting.  Three studies demonstrated the telemedicine 
intervention within community-based health centers and outpatient clinics, and all six studies 
included underserved populations and ethnic minorities.  No studies evaluated the effect of 
screening on treatment. 
Conclusion:  When utilized in the primary care setting, telemedicine is an effective 
intervention for increasing DR screening rates in patients with diabetes who otherwise face 
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access barriers to proper and timely eye care.  However, more rigorous research is needed before 
large-scale dissemination and implementation of this screening strategy can take place.   
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Introduction 
Diabetic retinopathy (DR) – a condition in which the retinal microvasculature is damaged 
through ischemia, neovascularization, hemorrhage, and edema – is the most common 
microvascular complication of diabetes 1 and is the leading cause of new cases of blindness 
among adults aged 20–74 years in the United States (U.S.). 2  Recent estimates reveal 4.2 million 
or 28.5% of people with diabetes over age 40 have DR and 655,000 of those with DR have 
advanced retinal disease that could lead to vision loss. 2  From 1997 to 2011, diabetic adults aged 
18 years or older who reported difficulty seeing despite glasses or contact lenses grew from 2.7 
million to 4.0 million. 3  By the year 2050, the prevalence of DR in Type I and Type II diabetic 
patients aged 40 and older is projected to increase to 16.0 million (from 5.5 million in 2005) and 
the prevalence of vision-threatening DR is projected to increase to 3.4 million (from 1.2 million 
in 2005).4 
DR is often asymptomatic at the time treatment is required.  Early screening and 
detection of retinal disease is therefore crucial to prevent the loss of vision.  Current screening 
guidelines by the American Diabetes Association (ADA) recommend an initial dilated eye exam 
by an ophthalmologist within 3-5 years of diabetes onset in adults and children older than 10 
years of age. 5  Additionally, an initial dilated exam by an ophthalmologist is imperative at the 
time Type II diabetes is diagnosed, since this disease can manifest before patients become aware 
of symptoms, and because almost 20% of people with Type II diabetes already have DR at the 
time of diagnosis.  Subsequent exams should occur yearly or more frequently in progressive DR. 
6,7 
Medical and surgical therapies have been shown to dramatically reduce the progression 
of DR.  Timely treatment with panretinal and focal laser photocoagulation surgery has been 
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shown in the ETDRS, DRS, and DRVS trials to reduce the risk of severe vision loss by over 
90%. 8–14  More recently, anti-VEGF therapy has also been shown to preserve visual acuity to a 
similar degree as laser therapy for proliferative DR. 15  However, despite recommendations, 
public awareness campaigns, and national and international DR screening guidelines established 
by leading eye care organizations and public health agencies, screening rates in the U.S. remain 
low.  Even with the inclusion of DR as a primary Healthcare Effectiveness Data and Information 
Set (HEDIS) compliance metric for the management of diabetic patients, on average, less than 
50% of patients with diabetes meet current screening recommendations. 16–19 
Barriers to receiving eye care harm efforts to raise DR screening rates to recommended 
levels and also compromise the quality and effectiveness of DR management and treatment.  As 
a consequence, patients with visual impairment from DR experience a loss of personal 
independence, loss of economic productivity and employment, and diminished quality of life. 2,20  
Socioeconomic and geographic barriers to care, delayed referrals from primary care providers, 
and lack of patient awareness regarding the importance of annual retinal exams have been cited 
as reasons for low screening rates.  Amid minorities, language and cultural barriers may also 
contribute to disparities in screening and treatment and low adherence to screening has been 
attributed to poor patient education. 17,19,21,22  
An emerging strategy for increasing compliance with DR screening recommendations, 
improving early detection of DR, and circumventing access barriers to eye care is the use of 
telemedicine for digital retinal imaging with remote expert interpretation.  Introducing retinal 
cameras at the level of the primary care provider could substantially reduce the access barriers 
that patients must otherwise overcome to obtain specialist eye care. 
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The main objective of this systematic review is to compile and analyze existing evidence 
on DR screening programs utilizing telemedicine in primary care settings.  The literature search 
was guided by the following focused PICO (population, intervention, comparator, outcome) 
question:  For diabetics who receive health care at a primary care center, how effective is DR 
screening utilizing digital retinal photography with remote interpretation at decreasing access 
barriers to eye care when compared to referral for a clinical exam by an eye care provider?  For 
this review, effectiveness of the intervention is defined by the ability of ocular telemedicine to 
increase DR screening rates in a study population of diabetics who face access barriers to eye 
care.  Referrals to eye care providers are also included. 
 
Methods 
To answer the PICO question, a PubMed search was performed on January 21, 2016 
using the following Medical Subject Headings (MeSH) phrases:  Diabetic retinopathy AND 
telemedicine AND (delivery of health care OR underserved OR minority groups OR minority 
OR minorities OR health services accessibility OR access OR medically underserved areas) 
AND (program evaluation OR evaluation OR effectiveness OR implementation). 
Limits were placed to include only English language articles published in the last 10 
years (January 2016 – January 2006).  No search limits were used for study design.  Articles 
were excluded if the title or abstract emphasized other interventions such as optical coherence 
tomography, or if they were technical papers on imaging and automated software analysis, 
predictive modeling, or cost-effectiveness.  International studies and technology assessments 
seeking to validate the accuracy of a specific telemedicine software were excluded.  Web of 
Science and EMBASE were also searched using the same strategy, and abstracts were reviewed 
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to determine relevance.  Hand searches of citations in the included articles were performed to 
identify other relevant studies.  After reading the full text of the included articles, data were 
abstracted by a single author (PDJ) and the following information was summarized in Table 1:  
Study design, technology and imaging techniques utilized, setting (location, population), patient 
demographics and proportion screened, DR classification and proportion of patients requiring 
referral to an eye care provider, and other comments.  The studies are arranged from highest to 
lowest by order of relevance. 
 
Results 
The PubMed search strategy returned 65 articles, Web of Science returned 18 articles, 
and EMBASE returned 52 articles.  Six articles were identified as meeting search criteria.  Only 
one study was a randomized controlled trial that explored the comparative effectiveness of 
telemedicine versus traditional surveillance for DR screening.  Three studies took place in the 
setting of community-based health centers and outpatient clinics.  All six studies included 
underserved populations and ethnic minorities, with two articles drawing a large number of 
patients from Native American reservations and communities.  Also, all six studies addressed the 
effect of telemedicine on screening rates for the diabetic population.  Although referral rates 
were addressed in every article, none of them evaluated the effect of screening on treatment. 
 
Mansberger, et al.: Tribal Vision Project 23,24 
 Mansberger, et al. is the most relevant study in this review, as it is the only long-term 
randomized controlled trial that investigates the comparative effectiveness of telemedicine versus 
traditional surveillance for obtaining a DR screening examination.  This 5-year study was 
Jani 57 of 75 
 
conducted at two primary care clinics that serve a large proportion of American Indian / Native 
Alaskan patients with diabetes.  Five hundred sixty-seven patients were recruited from two 
clinics and randomized into either the telemedicine arm or the traditional surveillance arm.  The 
telemedicine group received a larger proportion of DR screening exams (94.0%) when compared 
to the traditional surveillance group (56.0%) within one year of enrollment into the study.  In 
comparison to the traditional surveillance group, a larger proportion of patients in the 
telemedicine group obtained a DR screening exam in the ≤ 6 month time bin (94.6% vs. 43.9%) 
and the > 6 – 18 month time bin (53.0% vs. 33.2%).  However, patients in the traditional 
surveillance group were offered telemedicine screening after being enrolled in the study for 2 
years, and this modification in the intervention increased uptake of DR screening in this group.  
Even with some attrition in both groups over time, subsequent time bins showed that the 
difference in uptake between the telemedicine and traditional surveillance groups had changed as 
follows: > 18 – 30 months (44.3% vs. 39.5%), > 30 – 42 months (45.0% vs. 46.4%), and > 42 – 
54 months (51.1% vs. 56.0%).  Also, although a small group of patients chose to continue 
traditional surveillance despite being offered telemedicine, this gap eventually narrowed so that 
most patients (89.0%) were opting for DR screenings via telemedicine by > 42 – 54 months. 
No details were given on concealment of allocation, so it is unknown whether patients in 
the telemedicine arm were aware that their clinic’s primary care providers were consulting with 
an ophthalmologist via the internet rather than assessing fundus images and providing ocular 
diagnoses and recommendation plans on their own.  This detail becomes important when 
considering that these patients may not have been aware that they were receiving a specialist 
level of care in their primary care provider’s office. 
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Selection bias in this study was minimal since the telemedicine and traditional 
surveillance groups were similar in baseline demographic and medical characteristics (i.e., p 
values across various parameters were not significant).  
To confirm whether patients in the telemedicine and traditional surveillance arms were 
receiving their recommended DR screening exams, the study investigators captured exam data 
directly from patients’ medical records in the primary care office or via data entry forms that 
were faxed or mailed back to the primary care offices from outside eye care providers.  Thus, 
there was minimal measurement bias in this study because the same criteria were used for data 
reporting among both groups, and research staff were vigilant about contacting providers for 
missing data.  Also, two study investigators graded all fundus images using a standard protocol. 
Although selection and measurement bias were minimal, there may have been important 
sources of confounding that the authors did not adjust for in this study.  For example, social 
determinants of health such as education level and socioeconomic and insurance status could 
have played an important role in influencing whether patients sought DR screening from outside 
eye care providers in the traditional surveillance group.  These potential confounders could 
compromise the internal validity of this study.  Choosing the study population from two clinics 
in Oregon and Kansas that serve a large number of patients from a specific ethnic group could 
have compromised the external validity of this study because this patient group may face health 
care access barriers that are not generalizable to the larger population surrounding these clinics 
or to other geographic areas of the U.S. 
A potential limitation of this study may be that the authors did not collect data on patient 
insurance status, which could have affected whether patients in the traditional arm visited an 
ophthalmologist for DR screening exams.  The fact that patients in the traditional arm obtained 
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more DR screening exams after being offered the telemedicine option may imply that 
telemedicine effectively eliminated a potential access barrier that was otherwise keeping these 
patients from seeking diabetic eye care. 
 
Chin, et al.: California Native American Indian Reservations / UC Davis Medical Center 25  
In a retrospective cross-sectional study over a period of nearly five years, Chin et al. 
examined patients from nine remote, rural medical clinics and one urban academic medical 
center who had received nonmydriatic retinal screening for a history of nonadherence to annual 
retinal exams.  There was minimal selection bias in this study as all patients with diabetes were 
included regardless of whether they had any other dilated fundus exams in the past year.  Patients 
seen at the rural sites were younger and more likely to be American Indian and Alaskan Native 
compared to the population at the urban center.  Also, there was minimal measurement bias since 
all clinics used the same imaging protocol and all images were reviewed by a single 
ophthalmologist. 
Although it seems reasonable to assume that rural patients might have higher prevalence 
of DR because of limited access to specialist care, this study showed the opposite to be true; 
there was a significant difference in prevalence of DR between rural (12.6%) and urban (29.6%) 
patient populations who received retinal tele-screening (p < 0.001).  Despite this difference, 
HbA1c levels within 3 months of imaging were comparable for rural versus urban patients (8.3 ± 
2.1% vs. 8.3 ± 2.2%), suggesting that these two populations were similar in their glycemic 
control.  However, comparability of HgbA1c levels may be biased, as only 16.7% of rural 
patients’ HgbA1c levels were reported through the EyePACS telemedicine software, whereas 
96.9% of urban patients’ HgbA1c levels were accessible through the electronic medical records 
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system at the academic center.  Data was not collected on other potential confounders, such as 
socioeconomic factors, compliance with diabetes care, and insurance status, which could have 
contributed to these findings.  
The racial and ethnic diversity of the combined rural and urban study populations was a 
strength of this study.  Of note, patients from rural sites were primarily Native American, so the 
results from the rural sites may not be generalizable to rural populations elsewhere in the U.S.  
Further, Native Americans have the highest age-adjusted rate of diagnosed diabetes when 
compared to other ethnicities,26 but as shown in Table 1 below, they had a considerably lower 
prevalence of DR (12.1%) when compared to all other ethnicities in this study.  While there may 
be a variety of reasons for this outcome, such as differences in age, access barriers, education 
level, insurance coverage, or socioeconomic status, the significance of this finding is compelling:  
This study demonstrates that telemedicine is an effective strategy for reaching the underserved 
regardless of geographic location, race, ethnicity, or diabetes status; patients in rural settings who 
have limited access to eye care providers are just as likely to benefit from tele-screening as those 
in urban settings who may be non-adherent with retinal exams because of lack of awareness or 
other factors. 
 
Owsley, et al.:  Innovative Network for Sight (INSIGHT) 27 
 Owsley, et al. conducted a cross-sectional study across three urban outpatient clinics and 
one urban pharmacy clinic to determine the rate and types of DR that could be identified using 
telemedicine.  Overall, there were more females recruited from all four sites than males and the 
majority of study participants were ethnic minorities (88.0%).  The mean age at first diabetes 
diagnosis for patients at all sites was 44.5 years.  Of note, the majority of patients at the 
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University of Alabama site were African-American, whereas those at the University of Miami 
site were Hispanic, Haitian, or Cuban.  The Wake Forest outpatient clinic and the pharmacy 
clinic at Thomas Jefferson University saw a majority of white patients. 
Study participants at the various sites were similar in age, ethnicity, and the age at first 
diagnosis of diabetes.  Since a patient questionnaire was used to collect data on patient age at 
diabetes diagnosis, HgbA1c level, and date of most recent dilated eye exam, there could have 
been some recall bias associated with this data collection technique unless this information was 
verified in patients’ medical records. 
Only English-speaking participants were invited by physicians and staff to participate at 
each site except the University of Miami, which recruited both English- and Spanish-speaking 
patients.  In addition to having physicians and staff refer patients, the University of Miami also 
used flyers in English, Spanish, and Creole for recruitment.  Considering that patients who 
respond to flyers may have higher health literacy, this recruitment technique could have 
introduced some selection bias into the study.  Measurement bias was minimized because all 
images from all sites were sent to a central location where they were reviewed by a group of 
trained graders who were all using the same protocol. 
Participants at the pharmacy location in Philadelphia were more likely to be white, have 
health insurance, and to know their HgbA1c level.  The DR prevalence at this site was also lower 
than all other sites (15.8% vs. >23.0%), thus suggesting there may be some compliance bias 
present since those patients who visit the pharmacy may also be more compliant with their 
diabetes care.  Further, patients at the pharmacy site were more likely to have health insurance 
when compared to the other sites (79.2% vs. 34.6%), which could confound the study results 
because these patients may be more likely to seek health care in general. 
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The findings of this study are generalizable to the broader U.S. population because the 
clinics spanned four different geographic sites and several major ethnic minorities were 
represented.  However, the external validity may be compromised by the fact that all four clinics 
were affiliated with major academic centers, thus limiting generalizability to other rural and 
private clinics in these geographic locations or to non-English-speaking ethnic minorities. 
 
Velez, et al.:   Project I See in NC 28 
Velez, et al. was a particularly relevant study for this Master’s paper as it specifically 
targeted Medicaid and uninsured patients who receive diabetes care through two Community 
Care of North Carolina (CCNC) Networks which span a total of 35 clinic sites in the northwest 
and southern parts of the state.  A total of 1688 patients were included in this study, and the 
majority of patients were uninsured (59.1%). 
Patient demographics between the two CCNC networks were comparable, showing the 
authors tried to obtain a representative sample of participants by recruiting from two networks 
that encompass 12 counties and cover both urban and rural communities in North Carolina.  
Primary care offices, public health departments, hospital-based outpatient clinics, and free clinics 
for the uninsured were included in these networks. 
All images in this study were reviewed and initially graded by a physician who was not 
an ophthalmologist.  Images that were determined to have abnormal findings were triaged to a 
second grader, who was a certified retinal angiographer.  This methodology could have 
introduced measurement bias into the study if the first grader incorrectly marked an image as 
normal when it was actually abnormal since that would mean the second grader would not have 
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reviewed the image.  Measurement of inter- and intra-grader variability would have helped to 
determine whether this grading method introduced significant bias into the study. 
The Northwest Community Care Network had more patients who did not know what type 
of diabetes they had when compared to the Access III Lower Cape Fear Network (26.5% vs. 
1.1%).  The authors note that language barriers among the larger Hispanic population in the 
Northwest Community Care Network versus interviewer bias from a nurse who probed patients 
for detailed information in the Lower Cape Fear Network may have contributed to this difference 
between networks. 
The authors collected data on other variables (see “Comments” in Table 1 below) which 
may be potential confounders, but they did not control for these variables in the analysis, so it is 
unknown how they might have influenced the results of the study.  However, the study findings 
are generalizable to larger populations of patients with diabetes as several ethnic groups in both 
urban and rural settings were represented.  In particular, the study findings are generalizable to 
those on public insurance and those who are uninsured, but they may not be generalizable to 
those with private insurance. 
 
Olayiwola, et al.:  Community Health Center, Inc. 29 
The most interesting part of the retrospective, descriptive study by Olayiwola, et al. was 
that it took place in a large federally qualified health center (FQHC) in Connecticut that serves a 
high-risk population of minority patients who are mostly uninsured or publicly insured.  Over a 
period of one year, 568 patients with complete demographic and clinical data were screened for 
DR via telemedicine.  There were more women than men in the study (53.3% vs. 46.7%), and 
62.3% of the study population were Medicare or Medicaid recipients while 23.9% were 
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uninsured.  Participants were mostly Hispanics (41.9%), Whites (32.2%), and African-
Americans (12.7%).  Selection and measurement bias in this study were minimized because the 
investigators took a representative sample of underserved patients from the FQHC and all images 
from all sites were sent to a central location for review by a group of ophthalmologists.   
Although the authors collected clinical data on HgbA1c, duration of diabetes, and other 
comorbid conditions, they only provided descriptive statistics on these measures.  They did not 
explore other social determinants of health such as transportation barriers, education level, or 
employment status that could act as potential confounders within the study; these variables 
would play a significant role in diabetes care compliance in this FQHC population and would 
influence patient adherence to physician recommendations such as DR screening.  Although the 
overall prevalence of DR was low in this study population (25.5%), it is not possible to draw 
further conclusions without having more information and a more rigorous statistical analysis 
available. 
Findings of this study can be generalized to ethnic minorities and underserved 
populations that frequently obtain care at an FQHC, but the results may not be generalizable to 
others in the U.S. who have insurance and other means for obtaining health care. 
One of the strengths of this article was that the authors provided a detailed outline of their 
methodology for program implementation, which is useful when considering the operational 
scale-up of such a telemedicine screening program. 
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Discussion 
Overall, the evidence summarized in this literature review demonstrates that DR 
screening rates in underserved populations can be significantly improved by implementing 
retinal tele-screening programs in the primary care setting.  Although studies to date have been 
of good quality, major limitations still exist.  For example, sample sizes of patients with DR 
within larger study populations of patients with diabetes are still too small to adequately 
determine the effectiveness of telemedicine screening on subsequent DR treatment and long-term 
follow-up.  There is also a dearth of evidence on how social determinants of health influence 
diabetic eye care compliance.  Although this systematic review was fairly thorough, it was not a 
comprehensive review of all the available literature on this topic.  Since limits were placed for 
only English language articles on studies conducted in the U.S. in the past 10 years, it is possible 
that international studies addressing the topic of this review and the limitations of the current 
literature were not included.  
Although retinal tele-screening has been successful in delivering eye care to some of the 
most underserved patients, evidence for large-scale implementation of this intervention is still 
insufficient because ocular telemedicine has not yet been studied in a systematic manner.  Many 
diabetic eye care programs provide diabetes care via telemedicine assuming that this 
methodology works; however, rigorous studies to prove the power of this strategy in reducing 
the burden of suffering of DR are still lacking.  To date, most studies have mainly focused on 
proof of concept.  To truly determine the efficacy and effectiveness of telemedicine for 
community-based diabetes care, more research is needed through rigorous large cohort studies, 
randomized controlled trials, and systematic reviews.  Exploring community-level interventions 
and using community-based participatory research methods to evaluate the role and outcomes of 
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telemedicine interventions is also necessary.  Quasi experimental studies with pre- and post-test 
methodology could also be used to understand the effectiveness of ocular telemedicine in 
improving DR outcomes. 
Additionally, broader challenges within the American health care system need to be 
addressed before telemedicine models can be scaled-up and replicated on a national level.  For 
example, health policies around patient privacy, data security and information exchange, 
interstate physician licensure, and reimbursement have yet to be fully adapted to this new way of 
delivering care.  Until these issues are addressed, widespread adoption will continue to be a 
challenge.  As such, better evidence is needed through implementation science, feasibility, and 
cost-effectiveness studies.  Such information will be helpful for securing buy-in from key 
stakeholders such as state and local governments, hospitals, and grassroots community partners 
who would be essential in fostering the public-private partnerships necessary for further 
dissemination and implementation. 
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Table 1.  Summary of Selected Studies 
Study Technology / Imaging 
Technique 
Setting Patient Demographics 
and % Screened 
DR / Referrals to Eye 
Care Providers 
Comments 
Mansberger, et al. 23,24  
 
RCT study 
 
567 diabetics 
randomized from 
August 1, 2006 – 
September 31, 2009 and 
followed up to 5 years 
 
 
Nonmydriatic Nidek 
NM-1000 camera; 
Devers Eye Institute 
developed its own 
telemedicine platform 
 
Telemedicine arm:  
Captured 6 undilated, 
45 photos OU using 
modified Diabetic 
Retinopathy Study 
protocol: Stereo pair 
centered on optic disc, 
stereo pair centered on 
macula, one 
superotemporal image, 
one inferotemporal 
image 
 
Images read by 2 
experienced Devers Eye 
Institute investigators 
using an international 
classification scale and 
the Proliferative 
Diabetic Retinopathy 
study 
 
567 total patients 
screened from 
Yellowhawk Tribal 
Health Center, 
Pendleton, OR and 
Hunter Health Clinic, 
Wichita, KS  296 
randomized to 
telemedicine arm; 271 
randomized to 
traditional surveillance 
arm using random 
number generator 
 
Traditional arm: 
Patients received usual 
primary care (e.g., 
HbA1c testing) and 
were told to arrange a 
visit with a community 
eye care provider within 
1 year 
 
5 time bins for study 
participation: 
1.) ≤ 6 mos (-6 mos 
to +6 mos after 
enrollment) 
2.) > 6 – 18 mos 
3.) > 18 – 30 mos 
4.) > 30 – 42 mos 
5.) > 42 – 54 mos 
52% (295/567) females 
48% (272/567) males 
 
With primary, 
secondary, tertiary 
ethnicities combined:  
72.5% (411/567) non-
White and 50.3% 
American Indian/ 
Alaska Native 
 
75.6% (429/567) 
obtained DR screening 
exam  94% (278/296) 
in telemedicine arm; 
56% (151/271) in 
traditional arm 
 
24.3% (138/567) did not 
obtain DR screening 
exam 
 
 
 
 
Telemedicine arm:  
278/429 patients w/ DR 
exams 
 
72.3% no DR 
13.7% mild NPDR 
2.9% moderate NPDR 
0.0% severe NPDR 
1.8% PDR 
9.4% ungradable 
20.5% referred 
 
Traditional arm: 
151/429 patients w/ DR 
exams 
 
70.2% no DR 
13.9% mild NPDR 
7.9% moderate NPDR 
2.0% severe NPDR 
3.3% PDR 
2.6% ungradable 
24.5% referred 
 
DR prevalence by 
ethnicity: 
650 eyes = no DR 
 
159 eyes = with DR  
40.3% White 
20.8% American Indian 
/ Alaskan Native 
25.8% African-
American 
10.7% Hispanic / Latino 
2.5% Asian / other 
Collected data on age, 
gender, primary / 
secondary / tertiary 
ethnicity, systolic and 
diastolic blood pressure, 
HgbA1c, duration of 
diabetes 
 
Difference in baseline 
demographic and 
medical characteristics 
was not statistically 
significant between arms 
 
Used highest stage of 
DR between two eyes to 
define DR prevalence 
and stage 
 
Criteria for referral =  
1.) Moderate 
NPDR or worse 
2.) Presence of 
clinically 
significant 
macular edema 
(CSME) 
3.) Unable-to-
determine result 
from either eye  
 
Telemedicine screening 
was offered to patients 
in traditional arm after 2 
years of study 
enrollment 
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Study Technology / Imaging 
Technique 
Setting Patient Demographics 
and % Screened 
DR / Referrals to Eye 
Care Providers 
Comments 
Chin, et al. 25 
 
Retrospective cross-
sectional study from 
July 2006 – May 2011 
Rural clinics:  
Nonmydriatic Topcon 
TRC-NW6S with Nikon 
D80 camera back; 
EyePACS telemedicine 
platform 
 
Urban clinic: 
Nonmydriatic Nidek 
AFC-210 camera; 
ANKA telemedicine 
software 
 
 
Both clinics captured a 
single, undilated, 
nonstereoscopic 45, 10-
megapixel image of 
optic disc and macula 
OU 
 
All images from rural 
and urban clinics read 
by single retinal 
specialist at University 
of California Davis Eye 
Center 
 
872 patients from 9 rural 
clinics in California 
Native American Indian 
Reservations 
 
517 patients from 1 
urban family medicine 
clinic at Univ. of 
California Davis 
Medical Center, 
Sacramento, CA 
 
 
Rural clinics: 
59.2% female 
40.8% male 
 
60.1% Native American 
and/or Alaskan  
3.0% White non-
Hispanic  
0.2% Asian  
0.1% Black  
0.1% Native Hawaiian 
and other Pacific 
Islander  
0.1% Hispanic or Latino 
36.4% unspecified  
 
Urban clinic: 
55.5% female 
44.5% male 
 
27.3% White non-
Hispanic  
21.9% Black 
19.3% Hispanic or 
Latino 
17.0% Asian  
2.9% Native Hawaiian 
and other Pacific 
Islander 
1.4% Native American 
and/or Alaskan 
10.3% unspecified 
 
 
Rural clinics: 
73.3% (639/872) with 
no DR; 12.6% (110/872) 
with some level of DR 
 
17.6% ungradable 
images 
 
Urban clinic: 
56.1% (290/517) with 
no DR; 29.6% (153/517) 
with some level of DR 
 
14.3% ungradable 
images 
 
DR prevalence by 
ethnicity: 
12.1% Native American 
and/or Alaskan  
25.8% White non-
Hispanic 
30.7% Black 
26.7% Hispanic or 
Latino 
34.4% Asian  
31.3% Native Hawaiian 
and other Pacific 
Islander 
15.7% unspecified 
 
Referrals: 
All patients with 
detectable DR were 
examined by an eye care 
provider within weeks to 
months of tele-screening 
 
Collected data on age, 
gender, ethnicity, 
HgbA1c, fundus 
abnormalities other than 
DR 
 
Table 1 in paper: 
Participants in urban 
center tended to be older 
than those at rural sites 
(p < 0.001) 
 
Table 1 in paper: 
Participants in rural sites 
were more likely to be 
American Indian / 
Alaska Native (p < 
0.001) 
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Study Technology / Imaging 
Technique 
Setting Patient Demographics 
and % Screened 
DR / Referrals to Eye 
Care Providers 
Comments 
Owsley, et al. 27 
 
Cross-sectional study 
 
Univ. of Alabama – 
Birmingham: 
January 26 – July 24, 
2012 
 
Univ. of Miami: 
March 2, 2012 – April 
11, 2013 
 
Johns Hopkins / Wake 
Forest – Winston-Salem, 
NC: 
May 5, 2013 – 
November 14, 2014 
 
Thomas Jefferson Univ. 
– Philadelphia, PA: 
December 5, 2011 – 
March 29, 2013 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Nonmydriatic Nidek 
AFC-230 camera; Wills 
Eye Hospital 
telemedicine platform 
 
Clinics captured 3 
photos OU: Anterior 
segment, nasal fundus, 
and temporal fundus  
 
Images read by trained 
graders at Wills Eye 
Hospital telemedicine 
reading center using 
National Health 
Service’s DR grading 
classification system 
 
1894 total patients 
screened from 4 clinics 
 
3 outpatient clinics: 
Univ. of Alabama, 
Birmingham – Internal 
Medicine safety net 
clinic 
 
Univ. of Miami – FQHC 
serving uninsured / 
underinsured 
 
Johns Hopkins / Wake 
Forest Univ. – outpatient 
clinic serving low-
income people in 
downtown Winston-
Salem, NC 
 
1 urban outpatient 
pharmacy: 
 
Thomas Jefferson Univ. 
– outpatient pharmacy in 
Philadelphia, PA 
63.1% (1191/1894) 
females; 36.9% 
(696/1894) males 
 
Birmingham:  
31.7% (600/1894) 
diabetics screened 
29.5% insured 
84.3% African 
American 
14.5% White 
 
Miami:  
32.1% (608/1894) 
diabetics screened 
22.6% insured 
41.1% Hispanic 
33.9% African 
American 
11.5% Haitian 
11.0% Cuban 
 
Winston-Salem:  
9.5% (180/1894) 
diabetics screened 
51.7% insured 
68.9% African 
American 
21.1% White 
 
Philadelphia:  
26.7% (506/1894) 
diabetics screened 
79.2% insured 
68.2% African 
American 
18.8% White 
 
21.7% of all patients 
with any level of DR in 
either eye; 94.1% of 
these had background 
DR 
 
22.2% – 23.7% 
background DR in 
Birmingham, Miami, 
Winston-Salem vs. 
14.4% in Philadelphia 
 
0% – 11.4% 
preproliferative and 
proliferative DR across 
all sites 
 
9.3% maculopathy 
across all sites 
 
Overall DR prevalence 
similar for whites vs. 
combined ethnic/racial 
minorities (22.6% vs. 
21.6%) 
Used patient 
questionnaire to collect 
data on patient 
demographics, age at 
DM diagnosis, HgA1c 
level, date of most 
recent dilated eye exam, 
smoking status, and 
health insurance status 
 
Also looked at rate of 
other ocular findings 
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Study Technology / Imaging 
Technique 
Setting Patient Demographics 
and % Screened 
DR / Referrals to Eye 
Care Providers 
Comments 
Velez, et al. 28 
 
Descriptive, cross-
sectional study 
 
October 2005 – 
September 2007 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Unspecified camera 
type; Wake Forest 
School of Medicine 
telemedicine platform 
 
Two 45 photos OU: 
One centered on optic 
nerve and macula, one 
of superotemporal 
vascular arcade 
 
Images read by 2 trained 
graders (a physician and 
a certified retinal 
angiographer); a 
consulting 
ophthalmologist was 
available for challenging 
images 
1688 total patients 
screened from 2 
Community Care of 
North Carolina (CCNC) 
Networks  1030 from 
Northwest Community 
Care Network (12 sites) 
and 658 from Access III 
of Lower Cape Fear 
Network (23 sites) 
Access III of Lower 
Cape Fear Network: 
69% (456/658) females; 
31% (202/658) males 
 
50% African-American 
44% White 
5% Hispanic 
1% Other 
 
40% Medicaid 
2% Medicare 
58% Uninsured 
 
Northwest Community 
Care Network: 
64% (655/1030) 
females; 36% 
(375/1030) males 
 
40% African-American 
49% White 
10% Hispanic 
1% Other 
 
40% Medicaid 
0% Medicare 
60% Uninsured 
 
 
 
 
 
 
 
 
 
 
Access III of Lower 
Cape Fear Network: 
83.7% no DR 
9.3% mild NPDR 
5.8% moderate to severe 
NPDR 
0.9% PDR 
0.3% ungradable 
 
Northwest Community 
Care Network: 
87.5% no DR 
8.0% mild NPDR 
3.4% moderate to severe 
NPDR 
1% PDR 
0.1% ungradable 
 
Referrals: 
12% of total patients 
referred 
5% required urgent 
referral for vision-
threatening retinopathy 
 
All patients with 
moderate to severe 
NPDR or PDR were 
referred 
Patients’ pupils were 
dilated for retinal 
imaging using 1% 
tropicamide eye drops 
 no adverse reactions 
reported 
 
Used patient 
questionnaire to collect 
data on age, sex, race, 
previous history of 
dilated eye exam, 
duration of diabetes, 
self-reported vision 
changes in the previous 
year, knowledge of 
comorbid conditions, 
and awareness of any 
existing retinopathy 
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Study Technology / Imaging 
Technique 
Setting Patient Demographics 
and % Screened 
DR / Referrals to Eye 
Care Providers 
Comments 
Olayiwola, et al. 29 
 
Retrospective 
descriptive study 
 
Patients screened from 
July 2009 – June 2010 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2 nonmydriatic Canon 
CR-1 cameras rotated 
between multiple sites; 
EyePACS telemedicine 
platform 
 
Clinics captured 8 
images OU: 2 external, 
6 retinal 
 
Images read by 
ophthalmologists at Yale 
Eye Center / Dept. of 
Ophthalmology using 
EyePACS Retinopathy 
Grading System 
611 total patients 
screened (568 with 
complete demographic 
and clinical data) at 
multiple Community 
Health Center, Inc. 
primary care / FQHC 
sites 
 
Cameras were rotated 
between sites on a 
weekly basis 
46.7% (265/568) males; 
53.3% (303/568) 
females 
 
12.7% (72/568) Black 
3.2% (18/568) Asian 
32.2% (183/568) White 
41.9% (238/568) 
Hispanic / Latino  
0.5% (3/568) Native 
American / American 
Indian  
3.5% (20/568) Other 
6.0% (34/568) 
Unspecified 
 
23.9% (136/568) 
Uninsured 
62.3% (354/568) 
Publicly insured  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
74.5% (423/568) no DR 
 
25.5% (145/568) with 
some level of DR  
12.3% (70/568) mild 
NPDR  
6.9% (39/568) moderate 
NPDR 
3.7% (21/568) severe 
NPDR  
2.6% (15/568) PDR 
 
13% (75/568) required 
referral 
 
Collected data on age, 
gender, ethnicity, 
insurance status, 
duration of diabetes, 
HgbA1c, insulin 
therapy, hypertension, 
systolic and diastolic 
blood pressure, 
hyperlipidemia, 
coronary artery disease, 
chronic kidney disease  
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APPENDIX B:  The Partial Proportional Odds Regression Model 
 
We propose the cumulative logistic regression model for the three groups:  No DR, DR without 
referral and DR with referral.  Let their respective probabilities be defined as:  
P(Y=1) = P(No Diabetic Retinopathy)=π1 
P(Y=2) = P(Diabetic Retinopathy without Referral)=π2 
P(Y=3) = P(Diabetic Retinopathy with Referral) =π3 
with π1 + π2 + π3 =1.  The groups are ordered in the sense that DR with referral is the most severe 
and no DR is the least severe.  Define the cumulative logits: 
L1=log [π1/(π2+π3)]  and 
L2=log [(π1+π2)/π3].  
Specifically, L1 is log odds of no DR versus having a DR diagnosis, whereas the second logit is 
the log odds of no referral versus referral.  The cumulative logits model specifies that these logits 
depend upon covariates.  In particular, the final partial proportional odds model (Table 3) is: 
L1=α1+β11*Age+β21*Caucasian+β31*(Other Race) + β4*hgba1c+ β5*(Diabetes Duration) + 
β6*Stroke + β7*Kidney Disease 
L2=α2+β12*Age+β22*Caucasian+β32*(Other Race) + β4*hgba1c+ β5*(Diabetes Duration) + 
β6*Stroke + β7*Kidney Disease 
 
This model specifies proportional odds for HbA1c, diabetes duration, and kidney disease as 
evident by the common log odds ratio parameters in the two logits, which are β4, β5, and β6, 
respectively.  On the other hand, age and race have distinct regression coefficients in the two 
logits. 
